Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(17%)
Results Posted
50%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_3
1
17%
Ph phase_4
3
50%
Ph not_applicable
2
33%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
3(50.0%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(2)
Terminated(2)
Other(1)

Detailed Status

Completed2
Withdrawn1
Terminated1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (16.7%)
Phase 43 (50.0%)
N/A2 (33.3%)

Trials by Status

withdrawn117%
terminated117%
completed233%
recruiting117%
unknown117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DRUG
Total Trials
6